Pronova Announce Plans To Expand Into Consumer Healthcare

Norway’s Pronova Biopharma, best-known for their fish oil heart drug, Lovaza, from their partnership with GlaxoSmithKline, is to expand into the dietary supplement area of the consumer healthcare market. The Lysaker-based group, who research, develop and manufacture lipid therapies derived from nature, said that the move will build on their position as “the world’s largest

Continue Reading